Evidence map›Paper›PMID 25784579›Full record

Trial reportJournal of oncology practice2015

Outcomes and satisfaction after delivery of a breast cancer survivorship care plan: results of a multicenter trial.

Steven C Palmer, Carrie Tompkins Stricker, SarahLena L Panzer, Sarah A Arvey, K Scott Baker, Jackie Casillas, Patricia A Ganz, Mary S McCabe, Larissa Nekhlyudov, Linda Overholser and 5 more

Abstract readClinical TrialMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Journal of oncology practice, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Cancer survivor preferences for breast cancer follow-up care: a discrete choice experiment.Journal of cancer survivorship : research and practice · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Cancer survivorship programs at the Dana-Farber Cancer Institute.Journal of cancer survivorship : research and practice · 2024
    Review
  14. Article
  15. Advanced Practitioner-Led Shared Visits: A Novel Approach to Cancer Survivorship.Journal of the advanced practitioner in oncology · 2022
    Article
  16. Article
  17. Late effects in a high-risk population of breast cancer survivors.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022
    Article
  18. Engaging hematopoietic cell transplantation patients and caregivers in the design of print and mobile application individualized survivorship care plan tools.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2020
    Article
  19. Article
  20. The Integration of Survivorship Care Planning at a Comprehensive Cancer Center.Journal of the advanced practitioner in oncology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Steven C PalmerAbramson Cancer Center of the University of Pennsylvania, Philadelphia, PA; LIVESTRONG, Austin, TX; Fred Hutchinson Cancer Research Center, Seattle, WA; University of California, Los Angeles, Jonsson Comprehensive Cancer Center, Los Angeles, CA; Memorial Sloan Kettering Cancer Center, New York, NY; Dana-Farber Cancer Institute, Boston, MA; University of Colorado Cancer Center, Denver, CO; and University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC Stpalmer@mail.med.upenn.edu.
Carrie Tompkins StrickerAbramson Cancer Center of the University of Pennsylvania, Philadelphia, PA; LIVESTRONG, Austin, TX; Fred Hutchinson Cancer Research Center, Seattle, WA; University of California, Los Angeles, Jonsson Comprehensive Cancer Center, Los Angeles, CA; Memorial Sloan Kettering Cancer Center, New York, NY; Dana-Farber Cancer Institute, Boston, MA; University of Colorado Cancer Center, Denver, CO; and University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC.
SarahLena L PanzerAbramson Cancer Center of the University of Pennsylvania, Philadelphia, PA; LIVESTRONG, Austin, TX; Fred Hutchinson Cancer Research Center, Seattle, WA; University of California, Los Angeles, Jonsson Comprehensive Cancer Center, Los Angeles, CA; Memorial Sloan Kettering Cancer Center, New York, NY; Dana-Farber Cancer Institute, Boston, MA; University of Colorado Cancer Center, Denver, CO; and University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC.
Sarah A ArveyAbramson Cancer Center of the University of Pennsylvania, Philadelphia, PA; LIVESTRONG, Austin, TX; Fred Hutchinson Cancer Research Center, Seattle, WA; University of California, Los Angeles, Jonsson Comprehensive Cancer Center, Los Angeles, CA; Memorial Sloan Kettering Cancer Center, New York, NY; Dana-Farber Cancer Institute, Boston, MA; University of Colorado Cancer Center, Denver, CO; and University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC.
K Scott BakerAbramson Cancer Center of the University of Pennsylvania, Philadelphia, PA; LIVESTRONG, Austin, TX; Fred Hutchinson Cancer Research Center, Seattle, WA; University of California, Los Angeles, Jonsson Comprehensive Cancer Center, Los Angeles, CA; Memorial Sloan Kettering Cancer Center, New York, NY; Dana-Farber Cancer Institute, Boston, MA; University of Colorado Cancer Center, Denver, CO; and University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC.
Jackie CasillasAbramson Cancer Center of the University of Pennsylvania, Philadelphia, PA; LIVESTRONG, Austin, TX; Fred Hutchinson Cancer Research Center, Seattle, WA; University of California, Los Angeles, Jonsson Comprehensive Cancer Center, Los Angeles, CA; Memorial Sloan Kettering Cancer Center, New York, NY; Dana-Farber Cancer Institute, Boston, MA; University of Colorado Cancer Center, Denver, CO; and University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC.
Patricia A GanzAbramson Cancer Center of the University of Pennsylvania, Philadelphia, PA; LIVESTRONG, Austin, TX; Fred Hutchinson Cancer Research Center, Seattle, WA; University of California, Los Angeles, Jonsson Comprehensive Cancer Center, Los Angeles, CA; Memorial Sloan Kettering Cancer Center, New York, NY; Dana-Farber Cancer Institute, Boston, MA; University of Colorado Cancer Center, Denver, CO; and University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC.
Mary S McCabeAbramson Cancer Center of the University of Pennsylvania, Philadelphia, PA; LIVESTRONG, Austin, TX; Fred Hutchinson Cancer Research Center, Seattle, WA; University of California, Los Angeles, Jonsson Comprehensive Cancer Center, Los Angeles, CA; Memorial Sloan Kettering Cancer Center, New York, NY; Dana-Farber Cancer Institute, Boston, MA; University of Colorado Cancer Center, Denver, CO; and University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC.
Larissa NekhlyudovAbramson Cancer Center of the University of Pennsylvania, Philadelphia, PA; LIVESTRONG, Austin, TX; Fred Hutchinson Cancer Research Center, Seattle, WA; University of California, Los Angeles, Jonsson Comprehensive Cancer Center, Los Angeles, CA; Memorial Sloan Kettering Cancer Center, New York, NY; Dana-Farber Cancer Institute, Boston, MA; University of Colorado Cancer Center, Denver, CO; and University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC.
Linda OverholserAbramson Cancer Center of the University of Pennsylvania, Philadelphia, PA; LIVESTRONG, Austin, TX; Fred Hutchinson Cancer Research Center, Seattle, WA; University of California, Los Angeles, Jonsson Comprehensive Cancer Center, Los Angeles, CA; Memorial Sloan Kettering Cancer Center, New York, NY; Dana-Farber Cancer Institute, Boston, MA; University of Colorado Cancer Center, Denver, CO; and University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC.
Ann H PartridgeAbramson Cancer Center of the University of Pennsylvania, Philadelphia, PA; LIVESTRONG, Austin, TX; Fred Hutchinson Cancer Research Center, Seattle, WA; University of California, Los Angeles, Jonsson Comprehensive Cancer Center, Los Angeles, CA; Memorial Sloan Kettering Cancer Center, New York, NY; Dana-Farber Cancer Institute, Boston, MA; University of Colorado Cancer Center, Denver, CO; and University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC.
Betsy RisendalAbramson Cancer Center of the University of Pennsylvania, Philadelphia, PA; LIVESTRONG, Austin, TX; Fred Hutchinson Cancer Research Center, Seattle, WA; University of California, Los Angeles, Jonsson Comprehensive Cancer Center, Los Angeles, CA; Memorial Sloan Kettering Cancer Center, New York, NY; Dana-Farber Cancer Institute, Boston, MA; University of Colorado Cancer Center, Denver, CO; and University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC.
Donald L RosensteinAbramson Cancer Center of the University of Pennsylvania, Philadelphia, PA; LIVESTRONG, Austin, TX; Fred Hutchinson Cancer Research Center, Seattle, WA; University of California, Los Angeles, Jonsson Comprehensive Cancer Center, Los Angeles, CA; Memorial Sloan Kettering Cancer Center, New York, NY; Dana-Farber Cancer Institute, Boston, MA; University of Colorado Cancer Center, Denver, CO; and University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC.
Karen L SyrjalaAbramson Cancer Center of the University of Pennsylvania, Philadelphia, PA; LIVESTRONG, Austin, TX; Fred Hutchinson Cancer Research Center, Seattle, WA; University of California, Los Angeles, Jonsson Comprehensive Cancer Center, Los Angeles, CA; Memorial Sloan Kettering Cancer Center, New York, NY; Dana-Farber Cancer Institute, Boston, MA; University of Colorado Cancer Center, Denver, CO; and University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC.
Linda A JacobsAbramson Cancer Center of the University of Pennsylvania, Philadelphia, PA; LIVESTRONG, Austin, TX; Fred Hutchinson Cancer Research Center, Seattle, WA; University of California, Los Angeles, Jonsson Comprehensive Cancer Center, Los Angeles, CA; Memorial Sloan Kettering Cancer Center, New York, NY; Dana-Farber Cancer Institute, Boston, MA; University of Colorado Cancer Center, Denver, CO; and University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC.

Funding

Internet Studies to Enhance Long Term Survivorship after Hematologic MalignancyR01CA160684 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI SYRJALA, KAREN LESLIE · 2011 to 2015
$3.4M
NCI NIH HHS R01 CA160684
6 · The paper itself

Abstract

purposeSurvivorship care plans (SCPs) have been suggested to reduce fragmentation of care experienced by cancer survivors. Acceptance of SCPs is high, but trials in the United States are few. This pilot study used a quasiexperimental design to examine the outcomes achieved by breast cancer survivors receiving a standardized SCP visit at one of seven comprehensive cancer centers. MATERIALS AND

methodsOutcomes were assessed before and again 3 months after delivery of an SCP and included survivors' use of and satisfaction with SCPs, perceived knowledge about survivorship, and assessment of the quality and coordination of survivorship care.

resultsOne hundred thirty-nine survivors of breast cancer completed baseline and follow-up measures and received a standardized SCP visit. Participants most commonly used SCP materials to make decisions about exercise (64%), which tests to receive and when (62%), and dietary changes (62%). Only 21% shared the SCP with their primary care provider during that time. Satisfaction with the SCP was high, with 90% of participants reporting being at least satisfied with the SCP. Perceived knowledge about survivorship improved after SCP delivery, as did perceived care coordination and the provider's knowledge of the effects of cancer on survivors (all P < .001). Individuals closer to the time of diagnosis reported greater satisfaction with and use of SCPs.

conclusionThis study demonstrates improvements in perceived knowledge and quality of survivorship care after receipt of a comprehensive SCP. Survivors were satisfied with their SCP, and those closer to diagnosis reported greater satisfaction with and use of the materials.

Indexed as

Breast NeoplasmsContinuity of Patient CarePatient SatisfactionSurvivorsAdultAgedAged, 80 and overCancer Care FacilitiesFemaleHumansMiddle AgedPatient Care Planning

Identifiers

PMID25784579
PMCPMC5706128

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.